Published in JAMA on May 19, 2004
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med (2010) 2.93
The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma. JAMA Intern Med (2015) 2.68
Physician awareness of drug cost: a systematic review. PLoS Med (2007) 2.63
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract (2007) 2.51
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation (2009) 2.06
The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood) (2009) 2.02
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00
Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med (2007) 1.87
Patient Cost-Sharing and Hospitalization Offsets in the Elderly. Am Econ Rev (2010) 1.84
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med (2012) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
Medicare prescription drug coverage: consumer information and preferences. Proc Natl Acad Sci U S A (2006) 1.72
Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. JAMA Intern Med (2015) 1.71
Addressing asthma health disparities: a multilevel challenge. J Allergy Clin Immunol (2009) 1.66
Effect of cost-sharing on use of asthma medication in children. Arch Pediatr Adolesc Med (2008) 1.65
Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med (2008) 1.56
Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med (2007) 1.50
Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol (2013) 1.46
Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders. Psychiatr Serv (2012) 1.42
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Drug licenses: a new model for pharmaceutical pricing. Health Aff (Millwood) (2008) 1.39
Coping with prescription drug cost sharing: knowledge, adherence, and financial burden. Health Serv Res (2008) 1.38
How patient cost-sharing trends affect adherence and outcomes: a literature review. P T (2012) 1.37
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Arch Gen Psychiatry (2005) 1.30
The effect of pharmacy benefit design on patient-physician communication about costs. J Gen Intern Med (2006) 1.28
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Plan selection in Medicare Part D: evidence from administrative data. J Health Econ (2013) 1.25
Principles for evidence-based drug formulary policy. J Gen Intern Med (2005) 1.22
The new medicare drug benefit: formularies and their potential effects on access to medications. J Gen Intern Med (2005) 1.22
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health (2008) 1.20
The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Decis Mak (2008) 1.18
Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med (2008) 1.18
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices. Oncologist (2010) 1.12
Meaningful use of electronic prescribing in 5 exemplar primary care practices. Ann Fam Med (2011) 1.12
Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Am J Geriatr Psychiatry (2011) 1.11
Medication adherence and use of generic drug therapies. Am J Manag Care (2009) 1.08
The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med (2008) 1.08
Hospital admission rates for a racially diverse low-income cohort of patients with diabetes: the Urban Diabetes Study. Am J Public Health (2006) 1.08
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther (2012) 1.07
Steering patients to safer hospitals? The effect of a tiered hospital network on hospital admissions. Health Serv Res (2008) 1.07
Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries. Health Serv Res (2008) 1.06
From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine (2011) 1.05
Depression care for the elderly: reducing barriers to evidence-based practice. Home Health Care Serv Q (2006) 1.05
Racial/ethnic disparities in chronic diseases of youths and access to health care in the United States. Biomed Res Int (2013) 1.04
Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease. Prev Chronic Dis (2006) 1.02
Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol (2010) 1.02
Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Med Care (2013) 1.02
Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances. Diabetes Care (2009) 1.02
The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer. J Natl Cancer Inst (2014) 1.01
Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med (2013) 0.98
Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health (2010) 0.97
Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill. Patient Prefer Adherence (2010) 0.97
Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review. PLoS One (2014) 0.96
Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Am J Manag Care (2007) 0.96
Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs. Health Serv Res (2008) 0.95
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res (2008) 0.94
Pharmaceutical cost management and access to psychotropic drugs: the U.S. context. Int J Law Psychiatry (2005) 0.93
Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data. Health Serv Res (2009) 0.92
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J (2008) 0.92
Beliefs that influence cost-related medication non-adherence among the "haves" and "have nots" with chronic diseases. Patient Prefer Adherence (2011) 0.91
Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care (2011) 0.91
The impact of cost sharing on antidepressant use among older adults in British Columbia. Psychiatr Serv (2008) 0.91
Older patients' perceptions of medication importance and worth: an exploratory pilot study. Drugs Aging (2008) 0.90
The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees. Health Serv Res (2007) 0.89
Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database. Am Health Drug Benefits (2009) 0.88
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res (2014) 0.87
Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. Pan Afr Med J (2014) 0.87
Financial incentive increases CPAP acceptance in patients from low socioeconomic background. PLoS One (2012) 0.87
Does medication adherence following a copayment increase differ by disease burden? Health Serv Res (2011) 0.86
Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project. Clin Trials (2009) 0.86
Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res (2008) 0.85
Physician-patient communication on cost and affordability in asthma care. Who wants to talk about it and who is actually doing it. Ann Am Thorac Soc (2014) 0.85
Medication adherence: helping patients take their medicines as directed. Public Health Rep (2012) 0.84
Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes. J Am Geriatr Soc (2014) 0.84
Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs. Arch Intern Med (2010) 0.84
The Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential Impacts. Curr Diab Rep (2016) 0.84
Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications. Health Serv Res (2012) 0.83
Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. Circ Cardiovasc Qual Outcomes (2011) 0.82
Influence of refill adherence method when comparing level of adherence for different dosing regimens. Eur J Clin Pharmacol (2014) 0.82
Pharma rebates, pharmacy benefit managers and employer outcomes. Health Care Manag Sci (2010) 0.81
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy. Eur J Clin Pharmacol (2012) 0.81
A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci (2009) 0.81
Demand for prescription drugs under non-linear pricing in Medicare Part D. Int J Health Care Finance Econ (2013) 0.81
Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006. J Am Heart Assoc (2016) 0.80
An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.79
Perspectives in value-based insurance design for patients with diabetes: assessment and application. Am Health Drug Benefits (2011) 0.79
The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation. PLoS One (2016) 0.79
Did Medicare Part D reduce disparities? Am J Manag Care (2015) 0.79
Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes. Value Health (2012) 0.78
Coping with prescription medication costs: a cross-sectional look at strategies used and associations with the physical and psychosocial health of individuals with arthritis. Ann Behav Med (2012) 0.78
Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. Springerplus (2015) 0.78
Patient perspectives on having multiple versus single prescribers of chronic disease medications: results of a qualitative study in a veteran population. BMC Health Serv Res (2014) 0.77
Financial Distress in Cancer Patients. J Med Person (2013) 0.77
Behavioral hazard in health insurance. Natl Bur Econ Res Bull Aging Health (2013) 0.77
Assessing the effectiveness of health care cost containment measures: evidence from the market for rehabilitation care. Int J Health Care Finance Econ (2013) 0.77
Trends in patient cost sharing for clinical services used as quality indicators. J Gen Intern Med (2010) 0.77
Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users. J Am Geriatr Soc (2012) 0.76
Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.65
Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA (2007) 6.51
Employer drug benefit plans and spending on prescription drugs. JAMA (2002) 6.02
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes (2003) 5.11
Postmenopausal hormone replacement therapy: scientific review. JAMA (2002) 4.63
Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med (2004) 3.93
The evidence dilemma in genomic medicine. Health Aff (Millwood) (2008) 3.58
Benefit design and specialty drug use. Health Aff (Millwood) (2006) 3.44
Forecasting the nursing home population. Med Care (2003) 3.11
Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst (2002) 3.00
Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol (2010) 2.93
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Urologic diseases in America Project: analytical methods and principal findings. J Urol (2005) 2.87
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med (2009) 2.85
Male urethral stricture disease. J Urol (2007) 2.79
Evidence-based public health policy and practice: promises and limits. Am J Prev Med (2005) 2.43
A quantitative risk-benefit analysis of changes in population fish consumption. Am J Prev Med (2005) 2.33
A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med (2005) 2.27
Analysis of medication use patterns:apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm (2003) 2.16
Surgical treatment patterns among Medicare beneficiaries newly diagnosed with lumbar spinal stenosis. Spine J (2010) 2.09
Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol (2005) 2.00
Waiting times in California's emergency departments. Ann Emerg Med (2003) 1.95
Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood) (2005) 1.95
Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care (2003) 1.91
Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care (2006) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
Integrating evidence-based clinical and community strategies to improve health. Am J Prev Med (2007) 1.82
Does counseling by clinicians improve physical activity? A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 1.76
Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med (2013) 1.69
Expanding newborn screening: process, policy, and priorities. Hastings Cent Rep (2008) 1.62
Dialysis practices that distinguish facilities with below- versus above-expected mortality. Clin J Am Soc Nephrol (2010) 1.50
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin (2010) 1.39
A quantitative analysis of fish consumption and stroke risk. Am J Prev Med (2005) 1.39
Interstitial cystitis and painful bladder syndrome. J Urol (2007) 1.37
Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med (2010) 1.30
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine. Genet Med (2009) 1.26
The impact of consumer-directed health plans on prescription drug use. Health Aff (Millwood) (2008) 1.23
Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA (2003) 1.22
Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care (2005) 1.19
Lessons from cost-effectiveness research for United States public health policy. Annu Rev Public Health (2007) 1.08
Integrating clinical care and community health: delivering health. JAMA (2009) 1.06
Identifying best practices in dialysis care: results of cognitive interviews and a national survey of dialysis providers. Clin J Am Soc Nephrol (2008) 1.04
Bladder and upper tract urothelial cancer. J Urol (2007) 1.04
Kidney cancer. J Urol (2007) 1.02
Health in all policies for big cities. J Public Health Manag Pract (2014) 1.01
Medicare Part D: a successful start with room for improvement. JAMA (2008) 0.99
Erectile dysfunction. J Urol (2007) 0.98
Prostatitis. J Urol (2007) 0.98
Primary non-adherence of medications: lifting the veil on prescription-filling behaviors. J Gen Intern Med (2010) 0.97
Metabolic syndrome and hyperglycemia: congruence and divergence. Am J Cardiol (2006) 0.96
An opportunity map for societal investment in health. JAMA (2011) 0.96
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need. Transfusion (2012) 0.94
The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int (2009) 0.93
Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey. Clin J Am Soc Nephrol (2009) 0.93
A randomized controlled open trial of population-based disease and case management in a Medicare Plus Choice health maintenance organization. Prev Chronic Dis (2004) 0.93
Cryptorchidism and hypospadias. J Urol (2007) 0.93
Testis cancer. J Urol (2007) 0.93
Vesicoureteral reflux and ureteroceles. J Urol (2007) 0.93
Demographic and socioeconomic factors associated with blood lead levels among Mexican-American children and adolescents in the United States. Public Health Rep (2005) 0.91
Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Appl Health Econ Health Policy (2003) 0.91
The changing face of pharmacy benefit design. Health Aff (Millwood) (2004) 0.90
Aligning quality for populations and patients: do we know which way to go? Am J Public Health (2003) 0.89
Screening for overweight in children and adolescents: where is the evidence? a commentary by the childhood obesity working group of the US Preventive Services Task Force. Pediatrics (2005) 0.89
Male infertility. J Urol (2007) 0.89
Wiser investment for a healthier future. J Public Health Manag Pract (2012) 0.88
Disability forecasts and future Medicare costs. Front Health Policy Res (2004) 0.88
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation. Am Heart J (2013) 0.88
Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol (2012) 0.88
Costs and rehabilitation use of stroke survivors: a retrospective study of Medicare beneficiaries. Top Stroke Rehabil (2009) 0.87
Coverage and preventive screening. Health Serv Res (2010) 0.85
Medication costs: the role physicians play with their senior patients. J Am Geriatr Soc (2007) 0.85
Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings. Prev Chronic Dis (2005) 0.84
A health dividend for America: the opportunity cost of excess medical expenditures. Am J Prev Med (2012) 0.83
The relationship between urban sprawl and coronary heart disease in women. Health Place (2012) 0.81
Getting real performance out of pay-for-performance. Milbank Q (2008) 0.81
A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved (2005) 0.80
Moving towards better formulary management. Am J Manag Care (2005) 0.80
Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomes. Am J Kidney Dis (2010) 0.80
Early HIV treatment led to life expectancy gains valued at $80 billion for people infected in 1996-2009. Health Aff (Millwood) (2014) 0.80
Did Medicare Part D reduce disparities? Am J Manag Care (2015) 0.79
Newborn hearing screening: recommendations and rationale. Am J Nurs (2002) 0.78
Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation. J Comp Eff Res (2013) 0.78
Reassessment of cardiovascular risk in diabetes. Curr Opin Lipidol (2006) 0.77
Practice characteristics and HMO enrollee satisfaction with specialty care: an analysis of patients with glaucoma and diabetic retinopathy. Health Serv Res (2003) 0.77
Skin cancer prevention: sunnyside up or scrambled? J Natl Cancer Inst (2010) 0.77
Employee responses to health insurance premium increases. Am J Manag Care (2004) 0.76
Use of physicians' services for Medicare beneficiaries. N Engl J Med (2007) 0.75
Misaligned incentives in America's health: who's minding the store? Ann Fam Med (2005) 0.75
Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients. J Am Coll Cardiol (2014) 0.75
Pharmaceutical promotion, advertising, and consumers. Health Aff (Millwood) (2003) 0.75
So what? A framework for assessing the potential impact of intervention research. Prev Chronic Dis (2013) 0.75
Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. Am J Cardiol (2005) 0.75
Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia. Am J Manag Care (2012) 0.75